Articles

Elsevier,

The Lancet Regional Health - Europe, Volume 45, October 2024

The chief implication of this study for public policy is to support recommendations towards high-priority vaccination against COVID-19 in pregnant women to avoid high risks of adverse pregnancy outcomes from COVID-19 especially in the 3rd trimester.
Elsevier,

Heliyon, Volume 10, 15 October 2024

This study provides initial insights into the understudied issue of revealing or concealing strategies adopted by women living with Obstetric Fistula through the lens of Communication Privacy Management Theory. The decision to disclose or not has been established as a complex process which happens not as a one-time event but changes over time. Therefore, women living with Obstetric Fistula are coupled with the added burden of who, when, what and how they manage their diagnosis information. Providing interventions geared toward disclosure and non-disclosure strategies after diagnosis can provide enormous relief for these women.
Elsevier,

Chemical Engineering and Processing - Process Intensification, Volume 204, October 2024

"Celebrating Women in Process Intensification. This special issue highlights and celebrates the diversity of career pathways of women in process intensification. This perspective article explores individuals research field."
Elsevier,

Chemical Engineering and Processing - Process Intensification, Volume 204, October 2024

"Celebrating Women in Process Intensification. This special issue highlights and celebrates the diversity of career pathways of women in process intensification. This perspective article explores individuals research field."
Elsevier,

The Lancet Regional Health - Europe, Volume 45, October 2024

The main public health implication of all the available evidence is that COVID-19 vaccination is to be recommended to all women of reproductive age, especially those intending to become pregnant within a year.
Elsevier,

Clinical Lymphoma, Myeloma and Leukemia, Volume 24, October 2024

Women are significantly underrepresented in the field of hematology-oncology. Pivotal trials in the immune effector cell therapy show only 29.5% female authorship. This article examines the data and suggests strategies to decrease gendered authorship disparities.
Elsevier,

Chemical Engineering and Processing - Process Intensification, Volume 204, October 2024

"Celebrating Women in Process Intensification. This special issue highlights and celebrates the diversity of career pathways of women in process intensification. This perspective article explores individuals research field."
Elsevier,

Cell Genomics, Volume 4, 9 October 2024

The authors in this voices piece contributed to genetic research on non-invasive prenatal testing (NIPT) on an Asian cohort, as both pregnant women and non-European populations are under-represented in genomics datasets.
Elsevier,

Cell Genomics, Volume 4, 9 October 2024

A study of maternal genetics, milk composition and the infant faecal microbiome. The results show how an improved understanding of the genetics and genomics of human milk connects lactation biology with maternal and infant health.
Elsevier,

The Lancet Regional Health - Europe, Volume 45, October 2024

Analysis of the research used as a basis for clinical guideline development underscores the insufficient consideration of sex and gender in the primary evidence base informing the 2019 ESC guideline recommendations for chronic coronary syndromes. The underrepresentation of women in cardiovascular research and guideline development poses challenges for accurately discerning possible sex- and gender-specific effects and tailoring recommendations to diverse patient needs. Addressing these gaps requires explicitly integrating sex and gender considerations into study designs and guideline creation processes and promoting inclusivity to optimize clinical care provision and improve outcomes for all individuals affected by ischemic heart diseases.

Pages